A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 41/00 (2006.01)
Patent
CA 2437557
The invention relates to the use of reduced fluence rate PDT to treat neovasculature, particularly choroidal neovasculature (CNV). Reduced fluence rate PDT decreases the likelihood of molecular oxygen being the limiting factor in the photodynamic reaction so that the concentration of either photons (light intensity) or photosensitizer in the target tissue controls the photodynamic reaction.
L'invention concerne l'utilisation de la thérapie photodynamique à débit de fluence réduit (PDT) afin de traiter la néovascularisation, notamment la néovascularisation choroïdienne (NCR). La thérapie photodynamique à débit de fluence réduit (PDT) diminue les probabilités que l'oxygène moléculaire soit le facteur limitatif dans la réaction photodynamique de sorte que la concentration de photons (intensité lumineuse) ou de photosensibilisateur dans le tissu cible règle la réaction photodynamique.
Fetherstonhaugh & Co.
Qlt Inc.
LandOfFree
Reduced total fluence photodynamic therapy of choroidal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduced total fluence photodynamic therapy of choroidal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduced total fluence photodynamic therapy of choroidal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1920156